Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LXEO is expected to report earnings to rise 40.00% to -83 cents per share on December 15
Q3'25
Est.
$-0.84
Q2'25
Beat
by $0.31
Q1'25
Missed
by $0.10
Q4'24
Missed
by $0.06
Q3'24
Missed
by $0.17
The last earnings report on August 14 showed earnings per share of -60 cents, beating the estimate of -91 cents. With 411.46K shares outstanding, the current market capitalization sits at 281.35M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LXEO showed earnings on August 14, 2025. You can read more about the earnings report here.